Prostate adenocarcinoma is the second most commonly diagnosed cancer and the sixth most common cause of cancer-related mortality among men worldwide. Abstrak Adenokarsinoma prostat adalah kanker kedua tersering dan penyebab kematian ke enam terbanyak terkait kanker pada pria di seluruh dunia. Hubungan risiko dari keganasan kanker prostat di Asia dengan indeks massa tubuh (IMT) belum jelas diketahui. Tujuan dari penelitian ini adalah untuk mengetahui hubungan antara IMT dan skor Gleason pada pasien adenokarsinoma prostat di Indonesia. Penelitian ini merupakan penelitian dengan desain potong lintang, dilakukan di Rumah Sakit Umum Hasan Sadikin Bandung. Data yang digunakan merupakan data sekunder yang diambil dari rekam medis pasien adenokarsinoma prostat di Rumah Sakit Umum Hasan Sadikin. Data dianalisis menggunakan uji Chi kuadrat dan uji korelasi Spearman. Kami mengumpulkan data dari 95 subjek penelitian dan mendapat hasil 78 pasien dalam kisaran IMT normal. Dari kelompok tersebut 41 orang (52,6%) berada di skor Gleason tinggi. 17 pasien berada dalam rentang IMT tinggi, dan skor Gleason tinggi ditemukan pada 11 pasien (64,7%) pada kelompok tersebut (P = 0,362; rs = 0,094). Kami menyimpulkan tidak ada hubungan antara IMT pada pasien adenokarsinoma prostat dan skor Gleason di Indonesia.
Introduction
Prostate adenocarcinoma is the second most commonly diagnosed cancer and the sixth most common cause of cancer-related mortality among men worldwide. [1] [2] [3] It is the most common threat of cancer on male in many European countries, and there was the highest incidence of cancer on males in the USA. 2, [4] [5] [6] People with prostate adenocarcinoma in Europe based on European Cancer Observatory (ECO) in 2012 were 417.000 patients and in USA were 180.890 patients. 5, 6 Although much lower than that in Western countries and USA, the incidence of prostate cancer in the Asia has been rapidly increasing over the past few decades, including Indonesia. [7] [8] [9] People with prostate adenocarcinoma in Asia based on Globocan in 2008 were 122.000 patients. 10 In Indonesia based on Indonesian Society of Urologic Oncology in 2011 there were 971 patients. 8, 9 The epidemiological studies have shown that obesity has been associated with increased risk and death of multiple cancers, including prostate cancer. 3, 11, 12 The WHO estimates that today's obesity worldwide is doubled compared to 1980. 13, 14 In 2014, more than 1.9 billion people in world population were overweight ( BMI 25 kg/m 2 ). Of these over 600 million were has been also associated with higher recurrence rates after radiotherapy treatment, it was suggesting that obesity may influence prostate cancer aggressiveness and progression. 21 Indeed, among Asian men, several studies reported that a higher BMI had either positive or negative effects on the risk of prostate cancer (PCa) and high-grade PCa (HGPCa). 
Results
We collected data from the total number of 184 cases of prostate adenocarcinoma that were reported in this study period. In total, 89 data were excluded due to its incompleteness. figure 1 ). (see table 3 ). 
Discussion
There are many etiology of PCa, such as infection, heredity, smoking, and obesity. 13 One possible link in the relationship between obesity and prostate cancer (PCa) progression is inflammation. 13 Obesity produces a state of systemic chronic low-grade inflammation that can contribute to a number of chronic diseases, including advanced PCa. 23, 24 Inflammation can cause metabolic changes, such as insulin resistance. 3, 13 Increased insulin levels in body can make upregulation of the IGF-1 receptor that accompanies the transition of androgen-dependent cell lines to androgen independence, and IGF-1 promotes PCa progression in vivo. and 120 people had a high level of Gleason score (≥ 7). 20 From the data test results indicate that while there was no effect of BMI on the rate of positive prostate cancer biopsies, the rate of high Gleason scores was greater in the high BMI group than the normal BMI group, and it was different with the study in 2016 by Klaasen, et al., on Western and USA society that claimed obesity to be associated with higher level of Gleason score. 11, 20 Based on the results of this study, there are no relationship between BMI and Gleason score in Indonesian PCa patients. It is possible that in the Hasan Sadikin General Hospital, the prostate adenocarcinoma might be caused by other etiologies. The limitation of this study were limited status of body weight and height data measurement in Hasan Sadikin PCa patients and the accuracy of height measurement and weight was not properly standardized. We suggest subsequent study to do re-measurement for weight status and height of prostate adenocarcinoma patients.
Conclusion
There is no relation between BMI in Indonesian PCa and Gleason score in Hasan Sadikin General Hospital.
